Raleigh-Durham-Chapel Hill Area
2K followers 500+ connections

Join to view profile

About

Rare disease industry and foundation executive with deep leadership experience in…

Articles by Peter

  • A Mission-Driven Return on Investment

    Heading into the final quarter of my first year at RD Fund, I am energized by the momentum from our results achieved to…

    6 Comments
  • Gene Therapy...It's Time

    The rise and fall and resurgence of gene therapy is highly reminiscent of a similar pathway traveled by monoclonal…

    4 Comments
  • Thankful for $2.6B Drugs?

    The Tufts Center for the Study of Drug Development announced that it now estimates the cost to develop and win approval…

    2 Comments
  • M&A Tops 2009; Heavy Deal Flow To Continue

    Biopharma M&A volume this year has already topped 2009 and every year since. This statistic is impressive since: 1) we…

    2 Comments
  • Tax Inversion: What Is It? Why Should You Care?

    A great deal of biopharma M&A activity has been focused on tax inversions lately. This post, adapted from my July 30…

Activity

Join now to see all activity

Experience & Education

  • Foundation Fighting Blindness

View Peter’s full experience

See their title, tenure and more.

or

By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.

Licenses & Certifications

Volunteer Experience

More activity by Peter

View Peter’s full profile

  • See who you know in common
  • Get introduced
  • Contact Peter directly
Join to view full profile

Other similar profiles

Explore top content on LinkedIn

Find curated posts and insights for relevant topics all in one place.

View top content

Add new skills with these courses